MARKET

RVMDW

RVMDW

Revolution
NASDAQ
0.9100
+0.1099
+13.74%
Closed 15:23 12/12 EST
OPEN
0.8594
PREV CLOSE
0.8001
HIGH
0.9100
LOW
0.7900
VOLUME
27.97K
TURNOVER
--
52 WEEK HIGH
1.078
52 WEEK LOW
0.0305
MARKET CAP
--
P/E (TTM)
-0.1757
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVMDW last week (1201-1205)?
Weekly Report · 5d ago
Weekly Report: what happened at RVMDW last week (1124-1128)?
Weekly Report · 12/01 10:38
Revolution Medicines CFO Jack Anders Reports Sale of Common Shares
Reuters · 11/26 21:17
Revolution Medicines Director and Officer Mark A. Goldsmith Reports Sale of Common Shares
Reuters · 11/26 21:16
Weekly Report: what happened at RVMDW last week (1117-1121)?
Weekly Report · 11/24 10:45
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy
Seeking Alpha · 11/21 21:20
Revolution Medicines Director and Officer Mark A. Goldsmith Reports Disposal of Common Shares
Reuters · 11/20 21:24
Revolution Medicines General Counsel Jeff Cislini Reports Disposal of Common Shares
Reuters · 11/20 21:24
More
About RVMDW
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMDW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMDW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMDW stock methods without spending real money on the virtual paper trading platform.